跳至主要内容
临床试验/NL-OMON54192
NL-OMON54192已完成不适用

MultiSPectral fLuorescence Imaging as a Tool to separate healthy and disease related lymphatic anatomies during lymph node dissections in prostate cancer. - SPLIT study

Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 28 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Male, aged >= 18 years.
  • * WHO performance status 0,1, or 2.
  • * Written informed consent.
  • * Histopathologically confirmed adenocarcinoma of the prostate
  • * Increased risk of nodal metastases according to the MSKCC nomogram (> 7%)
  • * Scheduled for surgical (laparoscopic) prostatectomy including ePLND
  • * Suitable for RP and ePLND, as per institutional guidelines

排除标准

  • * Prostate cancer patients with prior abdominal or inguinal surgery
  • * History of allergy to iodine, food or medicinal induced urticaria, asthma,
  • eczema, or aller-gic rhinitis
  • * Hyperthyroid or thyroidal adenoma
  • * Kidney insufficiency
  • * History of oversensitivity to FLUORESCITE composites
  • * Patients using beta-blockers

研究者

发起方
Antoni van Leeuwenhoek Ziekenhuis

相似试验